Cardiovascular Systems, Inc.
CSII
CSII was delisted on the 27th of April, 2023.
167 hedge funds and large institutions have $693M invested in Cardiovascular Systems, Inc. in 2021 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 64 increasing their positions, 50 reducing their positions, and 35 closing their positions.
28% more repeat investments, than reductions
Existing positions increased: 64 | Existing positions reduced: 50
9% less first-time investments, than exits
New positions opened: 32 | Existing positions closed: 35
2% less funds holding
Funds holding: 171 → 167 (-4)
43% less capital invested
Capital invested by funds: $1.22B → $693M (-$528M)
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
+$14.1M |
| 2 |
Morgan Stanley
New York
|
+$12.9M |
| 3 |
Millennium Management
New York
|
+$12.3M |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$10.4M |
| 5 |
Neuberger Berman Group
New York
|
+$10.3M |
Top Sellers
CSII Hedge Fund Activity: Q4 2021 in Review
167 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Cardiovascular Systems, Inc. (CSII) for Q4 2021, worth a combined $693M — down 43% from $1.22B a quarter earlier.
Sellers outnumbered buyers: 35 funds closed out of CSII and 32 opened new positions — a net loss of 3 holders — while 50 trimmed existing stakes and 64 added.
The largest buyer was Citadel Advisors, adding an estimated $14.1M. The largest seller was RGM Capital, cutting an estimated $53.3M.
- 167 institutional investors held Cardiovascular Systems, Inc. (CSII) as of Q4 2021, down from 171 in Q3 2021.
- Funds reported $693M of Cardiovascular Systems, Inc. stock for Q4 2021, down 43% quarter-over-quarter.
- 32 funds opened new Cardiovascular Systems, Inc. positions in Q4 2021 and 35 closed out, a net change of -3 holders.
- The largest Cardiovascular Systems, Inc. buyer in Q4 2021 was Citadel Advisors, an estimated $14.1M added.
- The largest Cardiovascular Systems, Inc. seller in Q4 2021 was RGM Capital, an estimated $53.3M sold.
Based on aggregated 13F filings for Q4 2021.